A
Atea Pharmaceuticals, Inc.
AVIR · NASDAQ · Healthcare · 410M
Closing price
$5.15
-0.10% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.5×
Enterprise value / EBITDAEV/EBITDA
-2.0×
Free cash flow yieldFCF yield
-31.5%
Return on equityROE
-57.5%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.6×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.